Watchlist Price Alert

Pacira BioSciences Inc. (PCRX)

NASDAQ: PCRX · Real-Time Price · USD

25.97

-0.77 (-2.88%)

At close: Jun 06, 2025, 3:59 PM

25.97

0.00%

After-hours: Jun 06, 2025, 04:58 PM EDT

Pacira BioSciences Income Statement

Financials in USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019	Dec 31, 2018	Dec 31, 2017	Dec 31, 2016
Revenue	700.97M	674.98M	666.82M	541.53M	420.83M	421.03M	337.28M	286.63M	276.37M
Cost of Revenue	170.43M	184.67M	199.29M	140.25M	117.33M	106.71M	86.84M	87.92M	110.1M
Gross Profit	530.54M	490.31M	467.53M	401.28M	303.5M	314.31M	250.43M	198.72M	166.27M
Operating Income	-73.37M	87.67M	60.02M	131.06M	46.35M	38.11M	15.91M	-24.94M	-32.02M
Interest Income	19.69M	11.44M	4.54M	896K	4.63M	7.38M	6.5M	4.08M	1.32M
Pretax Income	-63.11M	61.7M	13.3M	56.4M	20.09M	-10.75M	-425K	-42.47M	-37.84M
Net Income	-99.56M	41.95M	15.91M	41.98M	145.52M	-11.02M	-471K	-42.61M	-37.95M
Selling & General & Admin	294.1M	269.44M	254.52M	199.34M	193.52M	200.78M	177.26M	161.49M	152.61M
Research & Development	81.58M	76.26M	84.8M	55.55M	59.42M	72.12M	55.69M	57.29M	45.68M
Other Expenses	228.23M	56.94M	57.29M	13.55M	7.87M	5.7M	-888K	167K	-82K
Operating Expenses	603.91M	402.63M	396.6M	268.44M	260.8M	278.6M	232.95M	218.78M	198.29M
Interest Expense	16.57M	20.31M	39.98M	31.75M	25.67M	23.63M	21.95M	18.05M	7.06M
Selling & Marketing Expenses	172.01M	153.04M	145M	111.02M	118.68M	129.66M	107.11M	94.8M	89.22M
Cost & Expenses	774.34M	587.3M	595.9M	408.7M	378.13M	385.32M	319.8M	306.7M	308.39M
Income Tax Expense	36.45M	19.75M	-2.61M	14.42M	-125.43M	268K	46K	140K	105K
Shares Outstanding (Basic)	46.24M	46.22M	45.52M	44.26M	42.67M	41.51M	40.91M	39.81M	37.2M
Shares Outstanding (Diluted)	46.24M	51.98M	46.54M	45.63M	43.68M	41.51M	40.91M	39.81M	37.24M
EPS (Basic)	-2.15	0.91	0.35	0.95	3.41	-0.27	-0.01	-1.07	-1.02
EPS (Diluted)	-2.15	0.81	0.34	0.92	3.33	-0.27	-0.01	-1.07	-1.02
EBITDA	32.25M	157.58M	144.78M	118.47M	71.42M	55.29M	33.05M	-10.59M	-17.86M
EBIT	-49.67M	79.01M	48.88M	85.4M	43.6M	11.17M	19.89M	-25.8M	-31.39M
Depreciation & Amortization	78.78M	75.57M	91.5M	28.55M	19.91M	19.58M	13.16M	13.83M	12.92M